I RUTH- forsøget forekom perifert ødem hos 14, 1% af de raloxifenbehandlede patienter og hos 11, 7% af de placebobehandlede patienter, hvilket var statistisk signifikant.
In the RUTH study, peripheral oedema occurred in 14.1% of the raloxifene-treated patients and 11.7% of the placebo-treated patients, which was statistically significant.